<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31661.017</object-id><label>Table 1.</label><caption><title>Severity of the actin isoform knockout phenotypes and their cross-compensation for each other correlate with their ribosome density.</title><p>See (<xref ref-type="bibr" rid="bib25">Perrin and Ervasti, 2010</xref>) for the references on the isoform knockout data. <bold>*</bold> From heterozygotes (since homozygous knockout is embryonic lethal) and knockout MEFs. <bold>&#8224;</bold> Tissue specific upregulation of different isoforms See (<xref ref-type="bibr" rid="bib4">Bunnell and Ervasti, 2010</xref>).</p><p><supplementary-material id="table1sdata1"><object-id pub-id-type="doi">10.7554/eLife.31661.018</object-id><label>Table 1&#8212;source data 1.</label><caption><title>Composite ribosome profiling data for the actin gene family, plotted in logarithmic scale.</title><p>Bottom panel shows the coarse curves for the data on top.</p></caption><media mime-subtype="jpeg" mimetype="image" xlink:href="elife-31661-table1-data1-v2.jpg"/></supplementary-material></p><p><supplementary-material id="table1sdata2"><object-id pub-id-type="doi">10.7554/eLife.31661.019</object-id><label>Table 1&#8212;source data 2.</label><caption><title>Ribosome profiling data for the individual members of the actin family, plotted in logarithmic scale.</title></caption><media mime-subtype="jpeg" mimetype="image" xlink:href="elife-31661-table1-data2-v2.jpg"/></supplementary-material></p><p><supplementary-material id="table1sdata3"><object-id pub-id-type="doi">10.7554/eLife.31661.020</object-id><label>Table 1&#8212;source data 3.</label><caption><title>Predictions of the secondary structures for &#946;&#8722; and &#947;&#8722; actin coding sequences.</title><p>Plot shows distance in nucleotides (x axis, 0 indicates the first ATG of the coding sequence) versus free energy (y axis).</p></caption><media mime-subtype="jpeg" mimetype="image" xlink:href="elife-31661-table1-data3-v2.jpg"/></supplementary-material></p><p><supplementary-material id="table1sdata4"><object-id pub-id-type="doi">10.7554/eLife.31661.021</object-id><label>Table 1&#8212;source data 4</label><caption><title>Predictions for the initial regions of the &#946;&#8722; and &#947;&#8722; actin coding sequence, compared to their codon-switched versions.</title><p>Plot shows distance in nucleotides (x axis, 0 indicates the first ATG of the coding sequence) versus free energy (y axis). &#946;-coded &#947;&#8722; actin mRNA is predicted to have a more relaxed structure around the translation initiation site, while being indistinguishable throughout the rest of the sequence.</p></caption><media mime-subtype="jpeg" mimetype="image" xlink:href="elife-31661-table1-data4-v2.jpg"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Name</th><th valign="top">Gene symbol</th><th valign="top">NCBI accession number, protein</th><th valign="top">NCBI accession number, mRNA</th><th valign="top">Composite ribosome density</th><th valign="top">Mouse knockout phenotype</th><th valign="top">Other actin isoforms upregulated upon knockout</th></tr></thead><tbody><tr><td valign="top">&#946;-cytoplasmic actin</td><td valign="top"><italic>Actb</italic></td><td valign="top">NP_031419</td><td valign="top">NM_007393</td><td valign="top">1351.607</td><td valign="top">Early embryonic lethality</td><td valign="top"><italic>Acta2</italic>; some <italic>Actg1</italic><bold>*</bold></td></tr><tr><td valign="top">&#945;-smooth muscle actin</td><td valign="top"><italic>Acta2</italic></td><td valign="top">NP_031418</td><td valign="top">NM_007392</td><td valign="top">53.781</td><td valign="top">Viable, with vascular contractility and blood pressure defects</td><td valign="top"><italic>Acta1</italic></td></tr><tr><td valign="top">&#945;-skeletal actin</td><td valign="top"><italic>Acta1</italic></td><td valign="top">NP_033736</td><td valign="top">NM_009606</td><td valign="top">10.267</td><td valign="top">Muscle weakness; postnatal lethality</td><td valign="top"><italic>Acta2</italic> and <italic>Actc1</italic></td></tr><tr><td valign="top">&#945;-cardiac actin</td><td valign="top"><italic>Actc1</italic></td><td valign="top">NP_033738</td><td valign="top">NM_009608</td><td valign="top">3.872</td><td valign="top">Perinatal lethality</td><td valign="top"><italic>Acta2</italic> and <italic>Acta1</italic></td></tr><tr><td valign="top">&#947;-cytoplasmic actin</td><td valign="top"><italic>Actg1</italic></td><td valign="top">NP_033739</td><td valign="top">NM_009609</td><td valign="top">1.289</td><td valign="top">Viable, with growth defects and progressive deafness</td><td valign="top"><italic>Acta2</italic>, <italic>Actb</italic>, <italic>Acta1</italic>, and <italic>Actc1</italic><bold>&#8224;</bold></td></tr><tr><td valign="top">&#947;-enteric smooth muscle actin</td><td valign="top"><italic>Actg2</italic></td><td valign="top">NP_033740</td><td valign="top">NM_009610</td><td valign="top">0.377</td><td valign="top">Unknown</td><td valign="top">Unknown</td></tr></tbody></table></table-wrap>